We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01099098
First Posted: April 6, 2010
Last Update Posted: May 12, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Hospital
April 4, 2010
April 6, 2010
May 12, 2011
January 2010
January 2011   (Final data collection date for primary outcome measure)
Prevalence of latent TB infection [ Time Frame: At enrollment ]
Not Provided
Complete list of historical versions of study NCT01099098 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
Not Provided
We easily regard nodules and fibrosis in upper lobes of lung as TB sequelae. The aim of this study is to confirm the prevalence of latent TB infection diagnosed by interferon-gamma release assay and tuberculin skin tests in patients with old healed TB.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients with TB sequelae in their CXR
Tuberculosis
Not Provided
  • Patients with TB sequelae
  • People without TB sequelae
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
480
March 2011
January 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age > 20 years
  • Patients with TB sequelae in their CXR

Exclusion Criteria:

  • Patients on immune-suppressants
Sexes Eligible for Study: All
20 Years to 80 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01099098
H-0909-054-295
No
Not Provided
Not Provided
Jae-Joon Yim / Associate Professor, Seoul National University Hospital
Seoul National University Hospital
Not Provided
Not Provided
Seoul National University Hospital
May 2011